Joseph Schlessinger PhD, MSc
William H. Prusoff Professor of Pharmacology; Chair, Pharmacology; Director, Cancer Biology Institute

Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Biochemistry, Biophysics and Structural Biology: Cell Cycle and Signal Transduction; Drug Design, Discovery and Mechanism; Membrane Biology and MotionSignal Transduction
Structural Biology
Pharmacology: Schlessinger Lab: Investigator
Diabetes Endocrinology Research Center
Center for X-Linked Hypophosphatemia, Yale
Research Interests
Growth factor receptors; Intracellular signaling pathways;protein kinases; phosphorylation; SH2, SH3 and other protein modules involved in signal transduction; drug discovery
Education
- B.S., Hebrew University of Jerusalem , 1968
- M.Sc., Hebrew University of Jerusalem , 1969
- Ph.D., Weizmann Institute of Science, Isarel , 1974
Selected Publication
- M.A. Lemmon and J. Schlessinger. Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 (2010).
Latest Honor and Recognition
- AACR International Award for Cancer(2010) , Penzcoller Foundation
Articles

Spring 2006
Six at Yale named to Institute of Medicine
Six Yale researchers, five from the School of Medicine and one from the School of Nursing, were elected to the...

Autumn 2011
Yale forms partnership to develop cancer drugs
Yale and Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., announced in late March that they...
Spring 2001
New chairs appointed in three departments; clinical leadership changes
Dean David A. Kessler, M.D., has announced the appointment of three new chairs to lead the departments of Cell Biology,...
Winter 2002
Three faculty members elected to American Academy of Arts and Sciences
Among the 211 new members inducted into the American Academy of Arts and Sciences in October, six were from Yale and...

Spring 2010
Biotech after the bust
After the U.S. and world economies faltered in the fall of 2008, it became clear that future plans for Yale’s various...

Autumn 2003
Building a better drug
The rational approach to drug discovery is changing pharmacology, but serendipity and imagination still play a starring...

Autumn 2006
The long war
Born in a war-torn mountain village in the former Yugoslavia, Yossi Schlessinger went on to fight other battles,...
Winter 2008
An atomic view of a protein offers insights into a new target for cancer drugs
A research team led by Joseph Schlessinger, Ph.D., the William H. Prusoff Professor and chair of pharmacology, has...



